A settlement between Pfizer and Ranbaxy means that the latter will be able to start selling its generic form of the cholesterol drug Lipitor by late 2011.
A report by the European Alliance for Access to Safe Medicines (EAASM) has revealed that 60% of medicines sold by online pharmacies are fake or substandard.
Archimedes Development and Ploughsgare Innovations have announced the licensing by Archimedes of a portfolio of patents relating to the use of chitosan for drug delivery.
GlaxoSmithKline (GSK) has received approval from the European Commission for oral Hycamtin (topotecan hard capsules) as a treatment for relapsed small cell lung cancer.
In light of the British Medical Journal's controversial article asserting that pharma KOLs are no more than glorified sales reps, do you think there should be more transparency in industry's dealings with influential doctors?
Yes
60%
No
17%
This warrants further investigation first
24%
Thank you for voting
SUMMARY: A round-up of the latest news, events and insightful editorial on the themes of regulatory and legal affairs in the European pharmaceutical industry.